Cargando…
888. In Vitro Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence
BACKGROUND: The integrase strand transfer inhibitor (INSTI)-based regimens bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF), dolutegravir (DTG)+FTC/TAF, DTG/lamivudine (3TC), and DTG/rilpivirine (RPV) are all used for treatment of HIV-infected patients. Here, relative time to in vitro v...
Autores principales: | Acosta, Rima K, Mulato, Andrew, D’Antoni, Michelle L, Yant, Stephen R, Cihlar, Tomas, White, Kirsten L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644010/ http://dx.doi.org/10.1093/ofid/ofab466.1083 |
Ejemplares similares
-
Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence In Vitro
por: Acosta, Rima K., et al.
Publicado: (2022) -
1448. Forgiveness of BIC/FTC/TAF: In Vitro Simulations of Intermittent Poor Adherence Find Limited HIV-1 Breakthrough and High Barrier to Resistance
por: Mulato, Andrew, et al.
Publicado: (2020) -
The Emergence of Resistance Under Firstline INSTI Regimens
por: Xie, Zhiman, et al.
Publicado: (2022) -
1563. Incidence of Errors in an INSTI-Based Era: A Comparison of Error Rates Between Single Versus Multiple Tablet INSTI-Based Regimens in the Inpatient Setting
por: Blackmon, Kayla, et al.
Publicado: (2023) -
Quantification of the Forgiveness of Drugs to Imperfect Adherence
por: Assawasuwannakit, P, et al.
Publicado: (2015)